Bristol-Myers Squibb Co. (BMY)

• Annual Data
• Quarterly Data

Bristol-Myers Squibb Co., common-size consolidated balance sheet: liabilities and stockholders’ equity

		Dec 31, 2018		Dec 31, 2017		Dec 31, 2016		Dec 31, 2015		Dec 31, 2014
	Short-term debt obligations
	Accounts payable
	Rebates and returns
	Employee compensation and benefits
	Research and development
	Dividends
	Royalties
	Branded Prescription Drug Fee
	Liabilities related to assets held-for-sale
	Litigation and other settlements
	Restructuring
	Pension and postretirement benefits
	Other
	Accrued liabilities
	Deferred income
	Income taxes payable
	Current liabilities
	Deferred income
	Income taxes payable
	Pension and other liabilities
	Long-term debt, excluding current portion
	Non-current liabilities
	Total liabilities
	Preferred stock, $2 convertible series, par value $1 per share
	Common stock, par value of $0.10 per share
	Capital in excess of par value of stock
	Accumulated other comprehensive loss
	Retained earnings
	Cost of treasury stock
	Total Bristol-Myers Squibb Company shareholders’ equity
	Noncontrolling interest
	Total equity
	Total liabilities and equity

Based on: 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13).